Impaired relaxing response to isoprenaline in isolated thoracic aorta of nephrotic rats: decrease in release of EDRF...

Area of Science:

• Cardiovascular Physiology
• Renal Pathophysiology
• Pharmacology

Background:

• Isoprenaline is a beta-adrenergic agonist used to study vascular smooth muscle relaxation.
• Nephrotic syndrome can lead to cardiovascular complications, including altered vascular function.
• Endothelium-derived relaxing factor (EDRF) plays a crucial role in vasodilation.

Purpose of the Study:

• To investigate the effect of nephrosis on isoprenaline-induced aortic relaxation in rats.
• To explore the role of the endothelium and nitric oxide (NO) signaling in this altered response.
• To examine the involvement of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) pathways.

Main Methods:

• Isolated aortic rings from control and daunomycin-induced nephrotic rats were used.
• Vascular relaxation responses to isoprenaline were measured.
• Experiments involved endothelium removal, and inhibitors of guanylate cyclase (methylene blue) and NO synthase (L-NAME) were employed.

Main Results:

• Nephrotic rat aortas exhibited significantly reduced isoprenaline-induced relaxation and cAMP accumulation compared to controls.
• Endothelial removal or inhibition of NO synthesis abolished the difference in relaxation and cAMP levels between groups.
• Isoprenaline did not affect tissue cGMP levels, but zaprinast revealed lower cGMP in nephrotic aortas.

Conclusions:

• Nephrosis impairs the relaxing response of rat aortas to isoprenaline, primarily via endothelial dysfunction.
• Endothelium-derived relaxing factor (EDRF) significantly potentiates isoprenaline-induced cAMP increase.
• Reduced endothelial-dependent cGMP release, possibly due to alpha 1-adrenoceptor activation, may underlie the diminished isoprenaline response in nephrotic rats.